Alan Cash serves as CEO and founder at MetVital, Inc. A serial entrepreneur, Mr. Cash has gained recognition and awards from the White House, INC 500 business, Ernst & Young Entrepreneur of the Year, Deloitte and Touche Technology Fast 50 and Top 100 Hotfirm. He has invented and brokered technology to major firms including Mitsubishi Heavy Industry (MHI), Vivendi, and has substantial experience dealing with US Federal regulatory agencies that have provided oversight for his work at the Department of Energy, the Department of Defense, and the Environmental Protection Agency. Mr. Cash provided the initial research into oxaloacetate and its stabilization, using the compound as a calorie restriction mimetic and glutamate scavenger. He has partnered with both academia and government to move this research forward, working with UCSD, UCLA, U of Kansas, Pennington Biomedical Laboratory, and the National Institute on Aging. Mr. Cash has an MS in physics from the University of Oklahoma.